Literature DB >> 10398674

Cellular biology of prion diseases.

D A Harris1.   

Abstract

Prion diseases are fatal neurodegenerative disorders of humans and animals that are important because of their impact on public health and because they exemplify a novel mechanism of infectivity and biological information transfer. These diseases are caused by conformational conversion of a normal host glycoprotein (PrPC) into an infectious isoform (PrPSc) that is devoid of nucleic acid. This review focuses on the current understanding of prion diseases at the cell biological level. The characteristics of the diseases are introduced, and a brief history and description of the prion hypothesis are given. Information is then presented about the structure, expression, biosynthesis, and possible function of PrPC, as well as its posttranslational processing, cellular localization, and trafficking. The latest findings concerning PrPSc are then discussed, including cell culture systems used to generate this pathogenic isoform, the subcellular distribution of the protein, its membrane attachment, proteolytic processing, and its kinetics and sites of synthesis. Information is also provided on molecular models of the PrPC-->PrPSc conversion reaction and the possible role of cellular chaperones. The review concludes with suggestions of several important avenues for future investigation.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10398674      PMCID: PMC100247          DOI: 10.1128/CMR.12.3.429

Source DB:  PubMed          Journal:  Clin Microbiol Rev        ISSN: 0893-8512            Impact factor:   26.132


  176 in total

1.  Prion protein-deficient cells show altered response to oxidative stress due to decreased SOD-1 activity.

Authors:  D R Brown; W J Schulz-Schaeffer; B Schmidt; H A Kretzschmar
Journal:  Exp Neurol       Date:  1997-07       Impact factor: 5.330

2.  Alterations in neurotransmitter-related enzyme activity in scrapie-infected PC12 cells.

Authors:  R Rubenstein; H Deng; C L Scalici; M C Papini
Journal:  J Gen Virol       Date:  1991-06       Impact factor: 3.891

3.  Molecular basis of phenotypic variability in sporadic Creutzfeldt-Jakob disease.

Authors:  P Parchi; R Castellani; S Capellari; B Ghetti; K Young; S G Chen; M Farlow; D W Dickson; A A Sima; J Q Trojanowski; R B Petersen; P Gambetti
Journal:  Ann Neurol       Date:  1996-06       Impact factor: 10.422

4.  Diversity of oligosaccharide structures linked to asparagines of the scrapie prion protein.

Authors:  T Endo; D Groth; S B Prusiner; A Kobata
Journal:  Biochemistry       Date:  1989-10-17       Impact factor: 3.162

5.  Abnormal properties of prion protein with insertional mutations in different cell types.

Authors:  S A Priola; B Chesebro
Journal:  J Biol Chem       Date:  1998-05-08       Impact factor: 5.157

6.  Prion protein expression in human leukocyte differentiation.

Authors:  V C Dodelet; N R Cashman
Journal:  Blood       Date:  1998-03-01       Impact factor: 22.113

7.  NMR characterization of the full-length recombinant murine prion protein, mPrP(23-231).

Authors:  R Riek; S Hornemann; G Wider; R Glockshuber; K Wüthrich
Journal:  FEBS Lett       Date:  1997-08-18       Impact factor: 4.124

Review 8.  Models of amyloid seeding in Alzheimer's disease and scrapie: mechanistic truths and physiological consequences of the time-dependent solubility of amyloid proteins.

Authors:  J D Harper; P T Lansbury
Journal:  Annu Rev Biochem       Date:  1997       Impact factor: 23.643

9.  The abnormal isoform of the prion protein accumulates in late-endosome-like organelles in scrapie-infected mouse brain.

Authors:  J E Arnold; C Tipler; L Laszlo; J Hope; M Landon; R J Mayer
Journal:  J Pathol       Date:  1995-08       Impact factor: 7.996

10.  The prion protein gene: a role in mouse embryogenesis?

Authors:  J Manson; J D West; V Thomson; P McBride; M H Kaufman; J Hope
Journal:  Development       Date:  1992-05       Impact factor: 6.868

View more
  53 in total

1.  A transmembrane form of the prion protein contains an uncleaved signal peptide and is retained in the endoplasmic Reticulum.

Authors:  R S Stewart; B Drisaldi; D A Harris
Journal:  Mol Biol Cell       Date:  2001-04       Impact factor: 4.138

Review 2.  Protein aggregates and dementia: is there a common toxicity?

Authors:  S Lovestone; D M McLoughlin
Journal:  J Neurol Neurosurg Psychiatry       Date:  2002-02       Impact factor: 10.154

3.  The mechanism of internalization of glycosylphosphatidylinositol-anchored prion protein.

Authors:  Claire Sunyach; Angela Jen; Juelin Deng; Kathleen T Fitzgerald; Yveline Frobert; Jacques Grassi; Mary W McCaffrey; Roger Morris
Journal:  EMBO J       Date:  2003-07-15       Impact factor: 11.598

4.  From conversion to aggregation: protofibril formation of the prion protein.

Authors:  Mari L DeMarco; Valerie Daggett
Journal:  Proc Natl Acad Sci U S A       Date:  2004-02-24       Impact factor: 11.205

Review 5.  Epigenetic control of aging.

Authors:  Ursula Muñoz-Najar; John M Sedivy
Journal:  Antioxid Redox Signal       Date:  2010-11-22       Impact factor: 8.401

6.  Mad cow and other maladies: update on emerging infectious diseases.

Authors:  Cristie Columbus
Journal:  Proc (Bayl Univ Med Cent)       Date:  2004-10

7.  Interaction of prion protein with small highly structured RNAs: detection and characterization of PrP-oligomers.

Authors:  Sara Vasan; Phyllus Y Mong; Abraham Grossman
Journal:  Neurochem Res       Date:  2006-06-02       Impact factor: 3.996

8.  Nonpolar substitution at the C-terminus of the prion protein, a mimic of the glycosylphosphatidylinositol anchor, partially impairs amyloid fibril formation.

Authors:  Leonid Breydo; Ying Sun; Natallia Makarava; Cheng-I Lee; Vera Novitskaia; Olga Bocharova; Joseph P Y Kao; Ilia V Baskakov
Journal:  Biochemistry       Date:  2007-01-23       Impact factor: 3.162

Review 9.  Cofactor molecules: Essential partners for infectious prions.

Authors:  Surachai Supattapone
Journal:  Prog Mol Biol Transl Sci       Date:  2020-08-24       Impact factor: 3.622

Review 10.  Immunotherapy in prion disease.

Authors:  Yvonne Roettger; Yansheng Du; Michael Bacher; Inga Zerr; Richard Dodel; Jan-Philipp Bach
Journal:  Nat Rev Neurol       Date:  2012-12-18       Impact factor: 42.937

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.